Showing results (41-50 of 209) with videos related to
Sort By:
Pageof 21
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
The role of HBsAg quantification for monitoring natural history and treatment outcomeMichelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBsAg quantification: useful for monitoring natural history and treatment outcomeMichelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Towards HBV curative therapiesRaymond F Schinazi, Maryam Ehteshami, Leda Bassit, et al.Journal of Gastroenterology and Hepatology|August 13, 2016
Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap modelJia-Horng Kao, Tarik Asselah, Xiao-Guang Dou, et al.Cancers|February 11, 2023
Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-AnalysisSylvain Bodard, Yan Liu, Sylvain Guinebert, et al.Journal of Viral Hepatitis|March 16, 2023
Prognostic value of genotyping in hepatocellular carcinoma: A systematic reviewSylvain Bodard, Yan Liu, Sylvain Guinebert, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2016
Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectivesTarik Asselah, Nathalie Boyer, David Saadoun, et al.Journal of Hepatology|October 10, 2020
COVID-19: Discovery, diagnostics and drug developmentTarik Asselah, David Durantel, Eric Pasmant, et al.Clinics in Liver Disease|November 6, 2007
Interferon therapy for chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.Journal of Hepatology|December 13, 2017
Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6Tarik Asselah, Tarek Hassanein, Imam Waked, et al.Pageof 21